List of All Articles with Tag 'lies'

A new survey has found that nearly half of adults in the United States are interested in taking prescription drugs for weight loss, such as Ozempic or Wegovy. In a KFF health tracking poll published on 3 August, researchers reported that 45 per cent of adults said they’d be interested in taking a “safe and effective” prescription drug for weight loss. Meanwhile, seven in 10 adults said they’ve heard at least “a little” about a new class of drugs being used for weight loss, with about one in five saying they have heard “a lot” about these drugs. Ozempic is a type 2 diabetes medication known for its weight loss side effects. Similar semaglutide injections, such as Wegovy and Mounjaro, have been specifically approved for the treatment of obesity and weight loss. This class of drugs called GLP-1 agonists works by mimicking a hormone called glucagon-like peptide 1 (GLP-1), regulating blood sugar levels and slowing down the rate at which food leaves the stomach to create the feeling of fullness. Of the US adults surveyed, older groups were some of the most aware of prescription weight loss drugs, with 76 per cent being those who have been told by a doctor in the past five years that they are overweight or obese. Nearly 60 per cent of those surveyed said they were currently trying to lose weight as well. While there was an overall interest in taking a prescription weight loss drug, that interest significantly decreased when people were asked whether they would take the medication as a routine injection. Only 16 per cent of adults said they would still take Ozempic or Wegovy, even if it wasn’t covered by their health insurance and was not specifically approved by the US Food and Drug Administration for weight loss. In fact, most people believed that insurance companies should cover the cost of weight loss drugs for adults who are overweight or obese, with an overwhelming 80 per cent of adults. Additionally, a large majority of adults believed the substantial profits that pharmaceutical companies have made from increased demand for weight loss drugs is a major factor contributing to the cost of injections like Ozempic and Wegovy. According to Novo Nordisk, the pharmaceutical company behind these prescription drugs for diabetes and weight loss, the list price for Ozempic can cost $935.77 per month without health insurance. Although the majority of adults said they trust pharmaceutical companies like Novo Nordisk to provide “reliable information” about safety and side effects of GLP-1 agonists, only 22 per cent said they trust these companies to price their products fairly. The FDA has listed the most common side effects of taking Wegovy as nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, and digestive disorders. More serious complications can occur from use of Wegovy or Mounjaro, such as the “potential risk of thyroid C-cell tumours,” pancreatitis, gallbladder problems, acute kidney injury, increased heart rate, and suicidal behaviour or thinking. Taking Ozempic can also lead to possible thyroid tumours, including cancer, pancreatitis, changes in vision, and kidney and gallbladder problems. Recently, several patients reported suffering from severe gastroparesis, also known as stomach paralysis, after taking the prescription weight loss medications. In a report from CNN, two people claimed that their “stomachs are paralysed” after taking Ozempic. “I wish I never touched it. I wish I’d never heard of it in my life,” Joanie Knight, a 37-year-old from Louisiana, told CNN. “This medicine made my life hell. So much hell. It has cost me money. It cost me a lot of stress; it cost me days and nights and trips with my family. It’s cost me a lot, and it’s not worth it. The price is too high.” One woman was also diagnosed with cyclic vomiting syndrome, which causes her to throw up multiple times a day. “I’ve almost been off Ozempic for a year, but I’m still not back to my normal,” said Emily Wright, a 38-year-old teacher from Toronto. Shortly after the report, the FDA shared in a statement with The Independent that it has become aware of stomach paralysis occurring among patients taking the medications. “The FDA has received reports of gastroparesis with semaglutide and liraglutide, of which some documented the adverse event as not recovered after discontinuation of the respective product at the time of the report,” the agency said. However, officials clarified that they were unable to determine whether taking Ozempic or Wegovy was the cause of stomach paralysis, or if it was caused by a different issue. “Gastroparesis can be a complication of diabetes that is related to long-standing or poorly controlled disease, further complicating the ability to determine what role the drugs played in the reported events,” the FDA added. In response to reports of stomach paralysis, drug manufacturer Novo Nordisk noted that these medications have been used to treat type 2 diabetes “for more than 15 years”, and for the “treatment of obesity” for eight years. “Semaglutide has been extensively examined in robust clinical development programs, large real world evidence studies and has cumulatively over 9.5 million patient years of exposure,” a spokesperson for Novo Nordisk said in a statement to The Independent. “Gastrointestinal (GI) events are well-known side effects of the GLP-1 class. For semaglutide, the majority of GI side effects are mild to moderate in severity and of short duration. GLP-1’s are known to cause a delay in gastric emptying, as noted in the label of each of our GLP-1 RA medications. Symptoms of delayed gastric emptying, nausea and vomiting are listed as side effects.” Read More Obese people on weight-loss jabs ‘should be prepared to stay on them for life’ Ozempic users report stomach paralysis as weight loss drug side effect: ‘I wish I never touched it’ Sharon Osbourne says she was ‘nauseous’ for weeks after taking Ozempic to lose weight Sharon Osbourne reveals what Ozempic did to her when she was taking it Ozempic users report stomach paralysis as side effect: ‘I wish I never touched it’ Lorraine Candy: ‘Perimenopausal rage made me unravel’

Trea Turner's terrible 2023 season is only getting worse.

Black parents and their children are more likely to experience unfair treatment when seeking medical care than others, a new study from the Urban Institute found.

Texas has separated at least 26 migrant family units on the southern border since July 10 under Gov. Greg Abbott's Operation Lone Star border initiative, according to Texas Rio Grande Legal Aid immigration attorney Kristin Etter.

Special counsel Jack Smith said Tuesday that the January 6, 2021 attack on the US Capitol was "fueled by lies" told by former President Donald Trump. The indictment of Trump on four new federal criminal charges, all related to the former president's effort to overturn his defeat in the 2020 election, lays out some of those lies one by one.

Stimulating the brain using electrodes could help ease symptoms of attention deficit hyperactivity disorder (ADHD) in children, a study has found. Transcranial random noise stimulation (tRNS) works by sending a mild electrical current to the brain through two electrodes on the scalp. The study, led by researchers from the University of Surrey and the Hebrew University of Jerusalem – and published in the Translational Psychiatry journal, explored the use of tRNS alongside cognitive training as a treatment for ADHD. Roi Cohen Kadosh, head of the School of Psychology and professor of cognitive neuroscience at the University of Surrey, said: “I believe that the scientific community is duty-bound to investigate and develop evermore effective and longer-lasting treatments for ADHD.” The clinical trial included 23 newly diagnosed and unmedicated children between the ages of six and 12, who were recruited from groups referred to the ADHD clinic by doctors, teachers, psychologists or parents. Researchers at the computerised neurotherapy lab at the Hebrew University of Jerusalem administered tRNS during cognitive training each weekday over a two-week period. The parents of 55% of the group reported “significant clinical improvement” in ADHD symptoms to researchers, compared to 17% in a control group that was given placebo brain simulation. Prof Kadosh said the findings demonstrate the treatment “has the potential to transform the lives of children and their families”. Future studies, with larger and more varied samples, should help establish this as a viable therapy for ADHD, and help us understand the underlying mechanisms of the disorder Dr Mor Nahum ADHD is a neurodevelopmental disorder and symptoms include hyperactivity, an inability to focus and impulsiveness. According to the National Institute for Health and Care Excellence (Nice), it is present in about 5% of children globally. Researchers are now preparing to start a larger clinical trial using tRNS and cognitive training. “If successful, this approach will be approved as a medical device for ADHD by the United States Food and Drug Administration,” Prof Kadosh said. Dr Mor Nahum is co-lead of the study and head of the computerised neurotherapy lab at the Hebrew University of Jerusalem. She added: “This is an important first step in offering new therapeutic options for ADHD. “Future studies, with larger and more varied samples, should help establish this as a viable therapy for ADHD, and help us understand the underlying mechanisms of the disorder.” Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live Black LGBTQ+ icons everyone should know Ashley James: ‘We have a totally warped idea of what a mum should be’ Host Maya Jama’s glamorous Love Island outfits cost over £10,000

NBA players from allover the world will be participating in this fall's FIBA World Cup.The 2023 FIBA World Cup will take place from Aug. 25 to Sept. 10 in the Philippines, Japan, and Indonesia. There will be a heavy NBA flavor at the event, with players from all over the world participating...

The Philadelphia Phillies are making a push for the postseason, and they solidified it by adding Michael Lorenzen from the Detroit Tigers. Let's grade the trade.The Philadelphia Phillies managed to sneak into the postseason last year and made a run to the World Series, where they fell just ...

MLB Rumors: Phillies, Blue Jays, Giants competing for Teoscar HernándezThe Mariners were busy on Monday, trading Paul Sewald to the Diamondbacks and AJ Pollock to the Giants. It does not sound like the front office is going to get a break going into the final hours of the MLB trade deadline...

Charlotte Dawson has welcomed her second child with fiancée Matt Sarsfield, several days after a “false alarm” that saw her rushing to the hospital. The reality star, 30, shared a photo of her cradling her newborn son while laying in a hospital bed on her Instagram Stories early on Sunday morning (30 July). She wrote in the caption: “Guys he’s here!!! I can’t believe it!!! I came in at 1am I had him by 2.13am.” Dawson, whose father was the late comedian Les Dawson, told her 1.3 million followers: “Can’t wait to update you all as soon as but Matthew has nipped to get me a Maccies [McDonald’s] and I’m having cuddles.” Dawson and Sarsfield, who have been engaged since 2020, are also parents to two-year-old son Noah. In another post, showing Sarsfield holding the baby, Dawson wrote: “He’s turned up with no Maccies ffs [sic]. But look at my beautiful baby daddy with our boyo [sic]. All happened so fast but thank you for being amazing Matt.” Several days earlier, Dawson revealed that she was rushed to hospital after her water had broken. However, it was a “false alarm” and she was sent home to wait until she went into labour. The Ex On The Beach and Celebs On The Farm star wrote in a post at the time: “Oh guys it’s been a bloody weird 24 hours… My waters broke last night but no pain, managed to sleep through it. Just getting checked now as movement’s been slow, happier I can hear his little heartbeat now.” Last year, Dawson revealed that she had suffered a miscarriage at 10 weeks that left her “heartbroken beyond words”. Her second baby has been dubbed her “rainbow baby”, a term that refers to a child born after the previous loss of a baby due to miscarriage, stillbirth, or death during infancy. She opened up about how she and Sarsfield were “over the moon” when they first discovered she was pregnant, but later it turned out it was “just not meant to be”. “Miscarriages are so common and not spoken about enough. We are so heartbroken right now, have no words and just don’t feel up to posting being my happy silly self right now,” she said. After learning that she was pregnant again, Dawson said she felt “very blessed and very happy”. “We were absolutely heartbroken about the miscarriage last year,” she added. “It came as a shock when I found out last April. It was like we’d just come to the realisation that we were having a baby and I lost it at 10 weeks.” Read More Blood, guts and cheap cuts: We need an alternative to eating animals – and ‘ethical meat’ isn’t the answer Strictly Come Dancing’s Janette Manrara gives birth to first child with fellow dancer Aljaz Skorjanec Jamie Lee Curtis says it is her ‘job’ to ‘fight’ against transphobia on behalf of daughter How to sleep during hot weather, according to experts How to keep your pet safe and healthy during a heatwave This is why you keep waking up at 4am – and what you can do about it

Exercises such as “wall sits” could be the best form of activity to help people reduce blood pressure, a new study suggests. Other physical activity including cardio, resistance training and HIIT workouts are also good for bringing down resting blood pressure levels, researchers found. But isometric exercises – those that involve engaging muscles without movement, such as wall sits and planks – provide the best results, they said. The study, published in the British Journal of Sports Medicine, saw researchers conduct analysis on previous studies looking at exercise and blood pressure. Some 270 studies were included in the final analysis which contained data on almost 16,000 people. They examined the impact different exercises had on systolic blood pressure, which notes the force at which the heart pumps blood around the body; and diastolic blood pressure, the resistance to the blood flow in the blood vessels between heartbeats when blood is pumped around the heart. The researchers, led by academics at Canterbury Christ Church University in Kent, found that there were significant reductions in resting blood pressure following cardio (aerobic exercise); dynamic resistance training, such as squats, press-ups and weights; high intensity interval training (HIIT); and combined training and HIIT. But the largest reductions were seen after isometric exercise training. A secondary analysis on specific types of exercises found the most benefit was seen among those who performed “isometric wall squats” and among runners. The academics said that current exercise recommendations for the prevention and treatment of high blood pressure are based on “older data” and suggest that it may be time to review the current guidelines. “Aerobic exercise training, dynamic resistance training, combined training, high-intensity interval training and isometric exercise training are all significantly effective in reducing resting systolic and diastolic blood pressure,” they wrote. “Overall, isometric exercise training is the most effective mode in reducing both systolic and diastolic blood pressure. “These findings provide a comprehensive data driven framework to support the development of new exercise guideline recommendations for the prevention and treatment of arterial hypertension.” For the average adult high blood pressure is considered to be from 140/90mmHg. When a person’s blood pressure is too high it puts extra strain on blood vessels, heart and other organs, such as the brain, kidneys and eyes. Persistent high blood pressure can lead to a number of serious health problems including heart attacks, strokes and vascular dementia. While there are medications which can help, people can make a number of life-style changes to help bring their blood pressure down including regular exercise, losing weight, cutting back on caffeine, alcohol and salt. Read More Dating app screenshot culture is out of control Husband fired from family business after wife roleplayed with reborn dolls The bowel cancer symptom George Alagiah wished he’d caught earlier Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live

People living with hepatitis B (HBV) and hepatitis C (HCV) could be just as likely or more likely to develop cancer than someone smoking a pack of cigarettes a day, new research suggests. According to the Center for Disease Analysis (CDA) Foundation, people infected with hepatitis B and C viruses “have a similar or significantly higher risk of developing cancer than someone who actively smokes one pack of cigarettes per day”, and therefore HBC and HBC should be “considered as cancer causing infections and international guidelines should be reconsidered accordingly”. Hepatitis is the term used to describe inflammation of the liver, according to the NHS. Hepatitis B is spread in the blood of an infected person – it can be spread from infected women to their babies, or through unprotected sex and injecting drugs – and hepatitis C is usually spread through blood-to-blood contact with an infected person. The NHS says HCV is most commonly spread in the UK through sharing needles used to inject drugs. The foundation found that HBV and HCV viruses are highly oncogenic. Oncogenes are mutated genes which can lead to cancers in multiple organs and sites. Homie Razavi, managing director at CDA Foundation said: “Hepatitis B and C infections are silent epidemics. These viral infections are cancer causing but since infected individuals don’t show any symptoms until it is too late, most infections go unnoticed. “It is important for all of us to recognise the high risk of cancer associated with hepatitis B and C infections and get patients linked to care. Treatment can reduce the risk of cancer by 85% or more.” As part of a call on World Hepatitis Day 2023 (July 28), the World Hepatitis Alliance (WHA) has launched a campaign called ‘We’re not waiting’ with its global network of 323 members in over 100 countries, in order speed up the fight against the disease, which claims a life every 30 seconds. In a new survey, the WHA found that 42% of people around the world are unaware that viral hepatitis is one of the leading causes of liver cancer. Nearly three-quarters (74%) of those surveyed said knowing that hepatitis causes liver cancer means they are more likely to get tested, whilst 82% would get vaccinated. In total, over 350 million people have been diagnosed with either hepatitis B or C around the world, which results in more than 1.1 million deaths every year. And by 2040, deaths caused by this disease could surpass mortality from malaria, HIV, and tuberculosis combined, according to the WHA. “Every year, more than a million lives are lost to hepatitis,” said Danjuma Adda, president of the WHA. “The theme of World Hepatitis Day 2023 is ‘We’re not waiting’. It’s a call to accelerate elimination efforts of viral hepatitis now and the urgent need for testing and treatment for the real people who need it. “Individuals and communities around the world are making change happen in their own lives and in [the] world around them. We celebrate them, while demanding more action. We’re not waiting for change – we’re fighting to make it happen.” Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live